ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.

Edmund K Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.